NCOA4介导的铁蛋白自噬通过维持铁硫簇蛋白的铁生物利用度成为胰腺癌依赖
胰腺导管腺癌(PDAC)依赖自噬生存,但自噬提供的代谢底物不明。利用患者来源和小鼠PDAC模型,本研究发现铁蛋白自噬在PDAC中上调以维持铁可用性并促进肿瘤进展,靶向NCOA4可延迟肿瘤生长并延长生存但出现补偿性铁获取途径,铁蛋白自噬表达特征升高预测PDAC患者预后不良。
要点
- 铁蛋白自噬在PDAC中上调,维持铁可用性以促进肿瘤进展。
- 铁蛋白自噬为铁硫簇蛋白合成提供铁,支持线粒体稳态。
- 靶向NCOA4可延迟肿瘤生长并延长生存,但出现补偿性铁获取途径。
核心结论
- 维持铁稳态是PDAC自噬的关键功能,NCOA4介导的铁蛋白自噬是PDAC的治疗靶点。
研究设计与样本
- 利用患者来源和小鼠PDAC模型进行的研究。
主要发现
- 铁蛋白自噬在PDAC中上调以维持铁可用性,从而促进肿瘤进展。
- 定量蛋白质组学显示铁蛋白自噬为铁硫簇蛋白合成提供铁以支持线粒体稳态。
- 靶向NCOA4导致肿瘤生长延迟和生存延长,但出现补偿性铁获取途径。
- 增强铁蛋白自噬加速PDAC肿瘤发生。
- 铁蛋白自噬表达特征升高预测PDAC患者预后不良。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Pancreatic ductal adenocarcinomas (PDAC) depend on autophagy for survival; however, the metabolic substrates that autophagy provides to drive PDAC progression are unclear. Ferritin, the cellular iron storage complex, is targeted for lysosomal degradation (ferritinophagy) by the selective autophagy adaptor NCOA4, resulting in release of iron for cellular utilization. Using patient-derived and murine models of PDAC, we demonstrate that ferritinophagy is upregulated in PDAC to sustain iron availability, thereby promoting tumor progression. Quantitative proteomics reveals that ferritinophagy fuels iron-sulfur cluster protein synthesis to support mitochondrial homeostasis. Targeting NCOA4 leads to tumor growth delay and prolonged survival but with the development of compensatory iron acquisition pathways. Finally, enhanced ferritinophagy accelerates PDAC tumorigenesis, and an elevated ferritinophagy expression signature predicts for poor prognosis in patients with PDAC. Together, our data reveal that the maintenance of iron homeostasis is a critical function of PDAC autophagy, and we define NCOA4-mediated ferritinophagy as a therapeutic target in PDAC. SIGNIFICANCE: Autophagy and iron metabolism are metabolic dependencies in PDAC. However, targeted therapies for these pathways are lacking. We identify NCOA4-mediated selective autophagy of ferritin ("ferritinophagy") as upregulated in PDAC. Ferritinophagy supports PDAC iron metabolism and thereby tumor progression and represents a new therapeutic target in PDAC. See related commentary by Jain and Amaravadi, p. 2023. See related article by Ravichandran et al., p. 2198. This article is highlighted in the In This Issue feature, p. 2007.
引用
- Santana-Codina N, Del Rey MQ, Kapner KS, et al. NCOA4-Mediated Ferritinophagy Is a Pancreatic Cancer Dependency via Maintenance of Iron Bioavailability for Iron-Sulfur Cluster Proteins. Cancer Discov. 2022. PMID: 35771492. doi:10.1158/2159-8290.CD-22-0043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。